ALAMEDA, Calif.--(BUSINESS WIRE)--Exelixis, Inc. (Nasdaq: EXEL) today announced detailed final overall survival (OS) results from CONTACT-02, a phase 3 pivotal study evaluating cabozantinib (CABOMETYX ...
Follow the Company on its website, LinkedIn or X. The Ocular Therapeutix logo and DEXTENZA ® are registered trademarks of Ocular Therapeutix, Inc. AXPAXLI™, PAXTRAVA™, ELUTYX™, and Ocular Therapeutix™ ...
BEDFORD, Mass., Sept. 12, 2024 (GLOBE NEWSWIRE) -- (NASDAQ: OCUL, “Ocular”), a biopharmaceutical company committed to ...
13d
The spotlight of the September 9 event will undoubtedly be the iPhone 16 series. However, Apple is also likely to announce a ...
BEDFORD, Mass., Sept. 05, 2024 (GLOBE NEWSWIRE) -- (NASDAQ: OCUL, “Ocular”), a biopharmaceutical company committed to improving vision in the real world through the development and commercialization ...
Researchers at Klick Labs unveiled a cutting-edge, non-invasive technique that can predict chronic high blood pressure (hypertension) with a high degree of accuracy using just a person's voice.
Maintaining good cardiovascular health during the first trimester of pregnancy may offset the genetic risk of developing preeclampsia and/or gestational hypertension, according to preliminary ...
The prevalence of hypertension is 22.7 percent among young adults aged 18 to 39 years and 5.4 percent among youth aged 8 to 19 years.
The US Food and Drug Administration gave Apple a green ligh for sleep apnea detection Apple Watch Series 9, Series 10, and ...
As part of the podium presentation, Brad Hauser, Chief Executive Officer of Autonomix, will discuss the latest developments in Autonomix’s minimally invasive nerve-sensing, ablation and verification ...
The National Agency for Food and Drug Administration and Control has raised the alarm over the circulation of substandard and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback